It’s my pleasure to announce that Nir Barzilai is a confirmed participant and speaker at our Towards a consensus definition of biological aging workshop, happening on the 23rd of April, 2020, in Cambridge, UK. Professor Barzilai is a key opinion leader in aging research and longevity and the main careful architect of the important TAME Trial. He is the director of the Institute for Aging Research at the Albert Einstein College of Medicine and the Paul F. Glenn Center for the Biology of Human Aging Research.
Current clinically focused biological aging research, or translational geroscience is going through incredible progress. However this emerging core consensus knowledge is not reflected in a flexible, formally correct and actionable definition of biological aging. The workshop is trying to make the first steps to address this problem by looking into several candidate definitions from different, biological, clinical, logical and computational angles to adopt a consensus definition.
Places are going to be extremely limited, if you are interested to participate please drop us a note at info at agecurve dot co dot uk.